News Medeon Biodesign, Inc.

Equities

6499

TW0006499007

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
42.45 ^TWD	-1.16%		+0.59%	-9.00%

Mar. 08	Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 18	Medeologix Inc. announced that it expects to receive TWD 315 million in funding from Medeon Biodesign, Inc.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 08	CI
Medeologix Inc. announced that it expects to receive TWD 315 million in funding from Medeon Biodesign, Inc.	Jan. 17	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-26	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-02	CI
Medeon Biodesign, Inc.(TPEX:6499) added to S&P Global BMI Index	22-09-19	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-05	CI
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-06	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-24	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-04	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-05	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-24	CI
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device	21-01-27	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-04	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-05	CI
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-06	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-20	CI
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Medeon Biodesign, Inc.

Equities

6499

TW0006499007

Summary

Filters